𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in adult patients with acute leukemia at first relapse

✍ Scribed by Paul Smits; Lia Schoots; Ben E. de Pauw; Theo de Witte; Rob S. G. Holdrinet; Jos T. P. Janssen; Clemens Haanen

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
423 KB
Volume
59
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ATM gene deletion in patients with adult
ATM gene deletion in patients with adult acute lymphoblastic leukemia
✍ Mohammad A. Haidar; Hagop Kantarjian; Taghi Manshouri; Chin-Yung Chang; Susan O' πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

## Background: Loss of heterozygosity (loh) at the atm gene (mutated in ataxia telangiectasia [at] patients) and atm protein deficiency occur in 14% and 34%, respectively, of patients with chronic lymphocytic leukemia (cll). atm protein deficiency also is associated with aggressive disease and wors

The use of higher dose clofarabine in ad
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia
✍ Bradley A. McGregor; Alexander W. Brown; Michael B. Osswald; Michael R. Savona πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 2 views

## Abstract The standard dose of clofarabine is 52 mg/m^2^ for pediatrics and 40 mg/m^2^ in adults. Clofarabine dosed at 52 mg/m^2^ was used in adult patients with refractory ALL to maximize response before allo‐HSCT. All patients had a significant response to therapy. Published pharmacokinetic ana